1. Home
  2. News
  3. Shanghai Serum Bio-Technology Co., Ltd.
  4. Announcement on Change of Chief Financial Officer
More Shanghai Serum Bio-Technology Co., Ltd. news
Shanghai Serum Bio-Technology Co., Ltd.SSE: 688163

Announcement on Change of Chief Financial Officer

Feb 8, 2025 · Issued by Shanghai Serum Bio-Technology Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Feb 8, 2025 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-change-of-chief-financial-officer-25

Shanghai Serum Bio-Technology Co., Ltd. on 6ix

Earlier from Shanghai Serum Bio-Technology

  • Announcement on Provision for Impairment of Long-term Equity InvestmentNov 23, 2024
  • Report for Q3 2024Oct 26, 2024
  • Announcement on Convening Q3 2024 Performance BriefingOct 22, 2024
  • Announcement on Resolution of the 1st Extraordinary General Meeting in 2024Oct 1, 2024
  • Announcement on Convening 2024 Semi-annual Performance and Cash Dividend BriefingSep 19, 2024

Later from Shanghai Serum Bio-Technology

  • Announcement on Preliminary Earnings Estimate for 2024Feb 26, 2025
  • Announcement on Using Some Temporarily Idle Raised Funds for Cash ManagementMar 21, 2025
  • Announcement on Changing Project Quality Control Reviewer of Audit InstitutionApr 9, 2025
  • Announcement on Convening Performance Meeting for 2024 and 1st Quarter of 2025Apr 22, 2025
  • Announcement on the Remuneration Plan for Directors, Supervisors and Senior Management Members in 2025Apr 26, 2025
All Shanghai Serum Bio-Technology news releases↗

Follow Shanghai Serum Bio-Technology into a list and get an email when it puts out news.

Follow Shanghai Serum Bio-Technology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer